Connection

Carlos Del Rio to Raltegravir Potassium

Back to Details
This is a "connection" page, showing publications Carlos Del Rio has written about Raltegravir Potassium.
Carlos Del Rio
Connection Strength
0.028
Raltegravir Potassium
  1. A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study. AIDS Res Hum Retroviruses. 2012 Oct; 28(10):1196-206.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.